The Use of Human Albumin for the Treatment of Ascites in Patients with Liver Cirrhosis: Item of Safety, Facts, Controversies and Perspectives

Publisher： Bentham Science Publishers

E-ISSN： 2212-3911|6|4|267-274

ISSN： 1574-8863

Source： Current Drug Safety, Vol.6, Iss.4, 2011-09, pp. : 267-274

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 6, 2015-06 ,pp. : 656-662

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 48, Iss. 1, 2018-01 ,pp. : 51-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

Variations in albumin use in patients with cirrhosis: An AASLD members survey

By  

HEPATOLOGY, Vol. 62, Iss. 6, 2015-12 ,pp. : 1923-1924

John Wiley & Sons Inc

Access to resources Recommend Favorite

Therapeutic effects of short‐ and intermediate‐term tolvaptan administration for refractory ascites in patients with advanced liver cirrhosis

By  

HEPATOLOGY RESEARCH, Vol. 45, Iss. 11, 2015-11 ,pp. : 1062-1070

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of acute kidney injury on prognosis of patients with liver cirrhosis and ascites: A retrospective cohort study

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 11, 2015-11 ,pp. : 1657-1665

John Wiley & Sons Inc

Access to resources Recommend Favorite